Bristol-Myers Squibb Pays $14M Over Alleged China Bribes
Bristol-Myers Squibb Co. on Monday agreed to pay $14 million to settle allegations by the U.S. Securities and Exchange Commission that its representatives in China bribed state-owned and state-controlled hospitals to...To view the full article, register now.
Already a subscriber? Click here to view full article